Data as of Jan 23
| +0.34 / +0.34%|
The 24 analysts offering 12-month price forecasts for CVS Caremark have a median target of 105.00, with a high estimate of 117.00 and a low estimate of 75.00. The median estimate represents a +4.35% increase from the last price of 100.62.
The current consensus among 28 polled investment analysts is to Buy stock in CVS Caremark. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.